arrow
R

Ruth Harvey

crick worldwide influenza centre and the francis crick institute
H指数:33
被引数:5,079

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Nomenclature for Tracking of Genetic Variation of Seasonal Influenza Viruses

季节性流感病毒遗传变异追踪的命名法

2026-02-130
OAAI
Resurgence of Zoonotic Highly Pathogenic Avian Influenza A(H5N1) Virus in Cambodia
2025-10-231
PRE
Third exposure to COVID-19 infection or vaccination differentially impacts T Cell responses

第三次暴露于COVID-19感染或疫苗接种对T细胞反应产生差异化影响

2025-08-210
OAAI
Improved Resolution of Influenza Vaccination Responses With High-Throughput Live Virus Microneutralisation

通过高通量活病毒微量中和技术提高流感疫苗接种反应的分辨率

2025-08-140
PREAI
Emergence of SARS-CoV-2 subgenomic RNAs that enhance viral fitness and immune evasion

SARS-CoV-2亚基因组RNA的出现,增强了病毒适应性和免疫逃逸能力

2025-01-211
OA
Near real-time data on the human neutralizing antibody landscape to influenza virus to inform vaccine-strain selection in September 2025

关于流感病毒的人类中和抗体谱的近实时数据,以指导2025年9月的疫苗毒株选择

2025-01-010
OAAI
Antigenic drift and subtype interference shape A(H3N2) epidemic dynamics in the United States
2024-09-254
OA
Divergent performance of vaccines in the UK autumn 2023 COVID-19 booster campaign
LANCET
IF88.5
2024-03-011
OAAI
A case of swine influenza A(H1N2)v in England, November 2023
2024-01-183
OAAI
SARS-CoV-2 mucosal neutralising immunity after vaccination
2024-01-013
OAAI
Neutralising immunity to omicron sublineages BQ.1.1, XBB, and XBB.1.5 in healthy adults is boosted by bivalent BA.1-containing mRNA vaccination and previous Omicron infection
2023-07-0113
OAAI
Strong peak immunogenicity but rapid antibody waning following third vaccine dose in older residents of care homes
2023-01-209
OAAI
WHO's Therapeutics and COVID-19 Living Guideline on mAbs needs to be reassessed
LANCET
IF88.5
2022-12-0125
OAAI
Antibody correlates of protection from SARS-CoV-2 reinfection prior to vaccination: A nested case-control within the SIREN study

疫苗接种前预防SARS-CoV-2再感染的抗体相关性: SIREN研究中的嵌套病例对照

2022-11-0123
OAAI
Functional immune responses against SARS-CoV-2 variants of concern after fourth COVID-19 vaccine dose or infection in patients with blood cancer

血癌患者在第四次新型冠状病毒肺炎疫苗剂量或感染后针对SARS-CoV-2变异的功能性免疫反应

2022-10-0116
OAAI